Guideline-recommended antibiotics in community-acquired pneumonia: Not perfect, but good

Archives of Internal Medicine

Volumn 169, Issue 16, 2009, Pages 1462-1464

  Sharpe, Bradley A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE SYSTEM; HUMAN; MORTALITY; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; GUIDELINE ADHERENCE; HUMANS; PNEUMONIA;

EID: 70349262649     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.272     Document Type: Editorial

References (14)

1. Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.
2. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med. 1999;159(21):2562-2572.
3. Dudas V, Hopefl A, Jacobs R, Guglielmo BJ. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother. 2000;34(4):446-452. (Pubitemid 30193774)
4. Arnold FW, Summersgill JT, LaJoie AS, et al; Community-Acquired Pneumonia Organization (CAPO) Investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007; 175(10):1086-1093.
5. Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med. 2006; 119(10):865-871. (Pubitemid 44415611)
6. Mortensen EM, Restrepo M, Anzueto A, Pugh J. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med. 2004;117(10):726-731. (Pubitemid 39482525)
7. Bratzler DW, Ma A, Nsa W. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project. Clin Infect Dis. 2008;47(suppl 3):S193-S201.
8. Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest. 2006;130(3):794-799. (Pubitemid 44423611)
9. Paul M, Nielsen AD, Gafter-Gvili A, et al. The need for macrolides in hospitalized community-acquired pneumonia: propensity analysis. Eur Respir J. 2007;30 (3):525-531. (Pubitemid 351182077)
10. Mills GD, Oehley MR, Arrol B. Effectiveness of β lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ. 2005;330(7489):456. (Pubitemid 40320547)
11. Robenshtok E, Shefet D, Gafter-Gvili A, Paul M, Vidal L, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev. 2008;(1):CD004418. doi:10 .1002/14651858.CD004418.pub3.
12. Arnold FW, LaJoie AS, Brock GN, et al; Community-Acquired Pneumonia Organization Investigators. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International Cohort Study results. Arch Intern Med. 2009;169(16):1515-1524.
13. McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009;169(16):1525-1531.
14. Venditti M, Falcone M, Corrao S, Licata G, Serra P; Study Group of the Italian Society of Internal Medicine. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med. 2009;150(1):19-26.